Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Sep '25 Sep 2, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	1,804	431	260	46	71	46	Upgrade
Market Cap Growth	252.12%	65.92%	464.37%	-35.49%	56.49%	-0.03%	Upgrade
Enterprise Value	1,699	421	215	32	54	28	Upgrade
Last Close Price	0.90	0.24	0.32	0.34	0.69	1.04	Upgrade
PB Ratio	16.97	3.86	5.86	8.60	2.52	2.32	Upgrade
P/TBV Ratio	16.97	3.86	5.86	8.60	2.52	2.32	Upgrade
Quick Ratio	9.32	9.78	5.42	1.50	9.16	10.88	Upgrade
Current Ratio	9.86	10.34	5.84	1.76	9.28	11.06	Upgrade
Return on Equity (ROE)	-126.21%	-73.94%	-177.51%	-188.41%	-113.20%	-108.08%	Upgrade
Return on Assets (ROA)	-68.90%	-41.82%	-85.39%	-90.05%	-63.81%	-61.53%	Upgrade
Return on Capital (ROIC)	-81.39%	-47.48%	-113.15%	-117.93%	-70.95%	-67.64%	Upgrade
Earnings Yield	-4.33%	-13.38%	-16.98%	-68.93%	-38.05%	-38.44%	Upgrade
FCF Yield	-	-13.65%	-17.40%	-64.50%	-36.22%	-35.71%	Upgrade
Buyback Yield / Dilution	-118.93%	-105.97%	-336.53%	-89.21%	-124.32%	-187.81%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.